Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Rodent models of diabetic kidney disease: human translatability and preclinical validity

Publikation: Bidrag til tidsskriftReviewpeer review

  1. Animal models of pain and migraine in drug discovery

    Publikation: Bidrag til tidsskriftReviewpeer review

  2. Reorienting the immune system in the treatment of cancer by using anti-PD-1 and anti-PD-L1 antibodies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. mTOR as a multifunctional therapeutic target in HIV infection

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Use of biomarkers in the discovery of novel anti-schizophrenia drugs

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Natural and therapy-induced antibodies to cytokines

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Increased vulnerability to Covid-19 in chronic kidney disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Kidney function and the prognostic value of myocardial performance index

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Reduced erythrocyte lifespan measured by chromium-51 in patients with type 2 diabetes undergoing long-term hemodialysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The Glycemic Effect of Liraglutide Evaluated by Continuous Glucose Monitoring in Persons with Type 2 Diabetes Receiving Dialysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease (ESRD). Except for SGLT2 inhibitors and GLP-1R agonists, there have been few changes in DKD treatment over the past 25 years, when multifactorial intervention was introduced in patients with type 2 diabetes mellitus (T2DM). The unmet clinical need is partly due to the lack of animal models that replicate clinical features of human DKD, which has raised concern about the utility of these models in preclinical drug discovery. In this review, we performed a comprehensive analysis of rodent models of DKD to compare treatment efficacy from preclinical testing with outcome from clinical trials. We also investigated whether rodent models are predictive for clinical outcomes of therapeutic agents in human DKD.

OriginalsprogEngelsk
TidsskriftDrug Discovery Today
Vol/bind26
Udgave nummer1
Sider (fra-til)200-217
Antal sider18
ISSN1359-6446
DOI
StatusUdgivet - jan. 2021

Bibliografisk note

Copyright © 2020 Elsevier Ltd. All rights reserved.

ID: 60985441